Dr. Flamm is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
161 Fort Washington Ave
New York, NY 10032Phone+1 212-305-0526Fax+1 212-305-0771
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematology and Medical Oncology, 1987 - 1990
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1983 - 1986
Columbia University Vagelos College of Physicians and SurgeonsClass of 1983
Certifications & Licensure
NY State Medical License 1984 - 2025
NE State Medical License 2022 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Lenalidomide in HTLV-1 Adult T-Cell Leukemia Start of enrollment: 2010 Dec 01
Publications & Presentations
PubMed
- 63 citationsGemcitabine for relapsed or resistant lymphomaDavid G. Savage, Simon Rule, M. Tighe, T. J. Garrett, M. W. Oster
Annals of Oncology. 2000-05-01 - 66 citationsTumor promoters induce membrane changes detected by fluorescence polarization.Paul B. Fisher, Michael Flamm, David Schachter, I. Bernard Weinstein
Biochemical and Biophysical Research Communications. 1979-02-28 - 28 citationsEffects of modulating erythrocyte membrane cholesterol on Rho(D) antigen expression.Mukul K. Basu, Michael Flamm, David Schachter, John F. Bertles, Alice Maniatis
Biochemical and Biophysical Research Communications. 1980-07-31
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
